The serum soluble scavenger with 5 domains levels: A novel biomarker for individuals with heart failure
Open Access
- 13 April 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 14
Abstract
Background: We aimed to explore the relationship between the serum Soluble Scavenger with 5 Domains (SSC5D) levels and heart failure (HF).Methods and Results: We retrospectively enrolled 276 patients diagnosed with HF or normal during hospitalization in Shanghai General Hospital between September 2020 and December 2021. Previously published RNA sequencing data were re-analyzed to confirm the expression profile of SSC5D in failing and non-failing human and mouse heart tissues. Quantitative real-time polymerase chain reaction assay was used to quantify Ssc5d mRNA levels in murine heart tissue after myocardial infarction and transverse aortic constriction surgery. To understand the HF-induced secreted proteins profile, 1,755 secreted proteins were investigated using human dilated cardiomyopathy RNA-seq data, and the results indicated that SSC5D levels were significantly elevated in failing hearts compared to the non-failing. Using single-cell RNA sequencing data, we demonstrated that Ssc5d is predominantly expressed in cardiac fibroblasts. In a murine model of myocardial infarction or transverse aortic constriction, Ssc5d mRNA levels were markedly increased compared with those in the sham group. Similarly, serum SSC5D levels were considerably elevated in the HF group compared with the control group [15,789.35 (10,745.32–23,110.65) pg/mL, 95% CI (16,263.01–19,655.43) vs. 8,938.72 (6,154.97–12,778.81) pg/mL, 95% CI (9,337.50–11,142.93); p < 0.0001]. Moreover, serum SSC5D levels were positively correlated with N-terminal pro-B-type natriuretic peptide (R = 0.4, p = 7.9e-12) and inversely correlated with left ventricular ejection fraction (R = −0.46, p = 9.8e-16).Conclusion: We concluded that SSC5D was a specific response to HF. Serum SSC5D may function as a novel biomarker and therapeutic target for patients with HF.Keywords
Funding Information
- National Natural Science Foundation of China (81870245 82070334)
This publication has 31 references indexed in Scilit:
- 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart FailureEuropean Journal of Heart Failure, 2016
- Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patientsClinical Proteomics, 2014
- Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptakeJournal of Leukocyte Biology, 2013
- Molecular cloning and analysis of SSc5D, a new member of the scavenger receptor cysteine-rich superfamilyMolecular Immunology, 2009
- Relationship Between Renal Function and Plasma Brain Natriuretic Peptide in Patients With Heart FailureJACC, 2006
- Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic PeptidesCirculation, 2005
- Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure BiomarkerCirculation, 2003
- Cloning of S4D-SRCRB, a new soluble member of the group B scavenger receptor cysteine-rich family (SRCR-SF) mapping to human Chromosome 7q11.23Immunogenetics, 2002
- Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridizationGenes, Chromosomes and Cancer, 2001
- Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosisBlood, 1995